Atossa Therapeutics ATOS
NASDAQ ATOS
$2.59 -0.05 (-1.89%)
At close: Aug 20, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Tax Rate (2020 - 2025)

Atossa Therapeutics (ATOS) posted quarterly Tax Rate of 84.39% for Q4 2024, down 5.77% quarter-over-quarter from 89.55% in Q4 2021.

Atossa Therapeutics (ATOS) Tax Rate (2020 - 2025) Analysis & Trends

Atossa Therapeutics (ATOS) has reported Tax Rate for 3 consecutive years, with 84.39% the latest figure, recorded in Q4 2024.

  • In Q4 2024, Tax Rate changed N/A year-over-year to 84.39%; the TTM figure through Sep 2025 stood at 17.75% (changed N/A YoY), while the FY2024 annual figure was 21.0%, changed N/A from the prior year.
  • Tax Rate retreated to 84.39% in Q4 2024 per ATOS's latest filing, from 89.55% in the prior quarter.
  • Across five years, Tax Rate topped out at 89.55% in Q4 2021 and bottomed at 50.03% in Q4 2020.
  • Historically, Tax Rate has averaged 74.66% across 3 years, with a median of 84.39% in 2024.
  • On a YoY basis, Tax Rate climbed as much as 3952 bps in 2021 and fell as far as 3952 bps in 2021.
  • Atossa Therapeutics' Tax Rate stood at 50.03% in 2020, then jumped by 79 bps to 89.55% in 2021, then decreased by 6 bps to 84.39% in 2024.
  • Business Quant data shows ATOS's Tax Rate at 84.39% in Q4 2024, 89.55% in Q4 2021, and 50.03% in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 15.11%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 10.91%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 24.15%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 7.49%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -16.71%
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 34.12%
10 Atossa Therapeutics 23.16 Mn 23.16 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 66.76%
Dec 31, 2025 66.76%
Dec 31, 2025 66.76%
Dec 31, 2024 84.39%
Dec 31, 2024 84.39%
Dec 31, 2024 84.39%
Dec 31, 2021 89.55%
Dec 31, 2021 89.55%
Dec 31, 2021 89.55%
Dec 31, 2020 50.03%
Dec 31, 2020 50.03%
Dec 31, 2020 50.03%